What amount sold does PLC SYSTEMS INC report in Form D filings?

The latest linked filings report $41.5M sold across 13 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was PLC SYSTEMS INC's most recent SEC filing?

PLC SYSTEMS INC's most recent Form D filing was on 2022-10-27.

How many investors does PLC SYSTEMS INC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does PLC SYSTEMS INC offer?

PLC SYSTEMS INC's SEC Form D filings indicate equity offerings.

PLC SYSTEMS INC

CIK: 0000879682·Biotechnology·ENGLEWOOD, CO·Corporation

Reported Sold

$41,534,250

Total Filings

Identified Offerings

Last Filed

Oct 27, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 27, 2022Form D — New notice

Reported sold: $14,675 · Target: $14,675

Rule 506(b)·1 investor

Jun 18, 2020Form D — New notice

Reported sold: $341,250 · Target: $10,000,000

Rule 506(b)·1 investor

May 4, 2020Form D — New notice

Reported sold: $3,225,875 · Target: $3,225,875

Rule 506(b)·9 investors

Dec 3, 2015Form D — New notice

Reported sold: $6,001,369 · Target: $6,001,369

Rule 506(b)·12 investors

May 27, 2015Form D — New notice

Reported sold: $12,000,000 · Target: $12,000,000

Rule 506(b)·20 investors

Oct 8, 2014Form D — New notice

Reported sold: $2,411,081 · Target: $2,411,081

Rule 506(b)·23 investors

Jun 10, 2014Form D — New notice

Reported sold: $500,000 · Target: $750,000

Rule 506(b)·1 investor

Jun 4, 2014Form D — New notice

Reported sold: $6,000,000 · Target: $6,000,000

Rule 506(b)·28 investors

Sep 27, 2013Form D — New notice

Reported sold: $1,750,000 · Target: $3,750,000

Rule 506(b)·7 investors

Feb 25, 2013Form D — New notice

Reported sold: $4,040,000 · Target: $11,250,000

Rule 506·27 investors

Jan 17, 2013Form D — New notice

Reported sold: $250,000 · Target: $250,000

Rule 506·1 investor

Jul 9, 2012Form D — New notice

Reported sold: $1,000,000 · Target: $1,000,000

Rule 506·1 investor

Mar 8, 2011Form D — New notice

Reported sold: $4,000,000 · Target: $4,000,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$2,562,415

Amendment Rate

Latest reported sold across 13 identified offerings

$41,534,250

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Mark R. Tauscher

Related Person

Appears on 3 filings

Carl Simpson

Related Person

Appears on 3 filings

Benjamin L. Holmes

Related Person

Appears on 3 filings

Brent Norton

Related Person

Appears on 3 filings

Gregory W. Mann

Related Person

Appears on 3 filings

Brigitte Smith

Related Person

Appears on 3 filings

Scott Durbin

Related Person

Appears on 3 filings

Daniel Janney

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 27, 2022	New	$14,675	$14,675	1
Jun 18, 2020	New	$10,000,000	$341,250	1
May 4, 2020	New	$3,225,875	$3,225,875	9
Dec 3, 2015	New	$6,001,369	$6,001,369	12
May 27, 2015	New	$12,000,000	$12,000,000	20
Oct 8, 2014	New	$2,411,081	$2,411,081	23
Jun 10, 2014	New	$750,000	$500,000	1
Jun 4, 2014	New	$6,000,000	$6,000,000	28
Sep 27, 2013	New	$3,750,000	$1,750,000	7
Feb 25, 2013	New	$11,250,000	$4,040,000	27
Jan 17, 2013	New	$250,000	$250,000	1
Jul 9, 2012	New	$1,000,000	$1,000,000	1
Mar 8, 2011	New	$4,000,000	$4,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

GelSana Therapeutics, Inc.

Biotechnology

Offering target: $4,931,726

Filed Oct 8, 2026